BGI Genomics Monthly Spotlight - August 2024
BGI Genomics
BGI Genomics, based in China, is the world’s leading provider of genetic tests and sequencing services.
Largest Multi-Omics Study Unveils Prognostic Genetic Insights in Colorectal Cancer
The Institute of Intelligent Medical Research (IIMR) at BGI Genomics, teamed up with Uppsala University and published the largest-ever multi-omics study on Colorectal Cancer in the influential Nature journal.
This landmark research uncovers new genetic alterations and develops a cutting-edge molecular classifier for tumor variants, offering fresh insights into the functional and prognostic impact of somatic mutations.
Research reveals: Gut bacterium Megamonas tied to obesity risk | BGI Insight
A recent study published in Cell Host & Microbe reveals that a gut bacterium, Megamonas, is linked to obesity. ?
The study, led by Ruijin Hospital, BGI Research and BGI Genomics involved over 1,000 participants and leveraged Whole Genome Sequencing to show Megamonas boosts lipid absorption, leading to weight gain.?
WHO Declares Mpox Outbreak a Global Health Threat | BGI Insight
WHO declares Mpox outbreak a public health emergency of international concern (PHEIC) for the second time, emphasizing the critical role of testing in combating this global threat.
BGI Genomics, through its subsidiary GBI, has developed the Monkeypox Virus (MPV) Detection Kit, utilizing PCR-fluorescence probing technology to support global efforts in controlling and eliminating the outbreak.
Together, we can make a difference!
Transform Olympic Spirit into Everyday Health | Proud of you
??♀???Right on time for the Olympic season, we caught up with the BGI Genomics Team:
·?Kerri Xu, PR Manager
·?Brenno Castro, Sales Manager for Europe and Africa
·?Jin Lee, Senior Sales Representative at Research Services at BGI Genomics
These three BGIers share insights about their favorite athletes, personal health journeys, and how the Olympics motto "Faster, Higher, Stronger" inspires their approach to health management and reaching new heights.
Targetable Ovarian Cancer Variant RAD51D Found in Chinese Patients | BGI Insight
BGI Genomics and Fudan University have unveiled the germline mutational landscape, highlighting an enriched RAD51D variant unique to the Chinese population.
This discovery could be a game-changer in ovarian cancer management and may offer new therapeutic possibilities.
BGI Genomics at HGSA Annual Scientific Meeting
Good times at the 47th HGSA Annual Scientific Meeting in Gold Coast! ?
Besides engaging with the latest advancements in human genetics and maternal health, Albert Hsing and our Aussie team stayed busy promoting our DNBSEQ? technology, NIFTY? test, and VISTA? carrier screening.
Lab technician | chemist | ISO9001| I have (6) years experience with Saudi Aramco |QA/QC Supervisor with Saudik contracts with Aramco
3 个月I hold an Associate Diploma in Industrial Chemistry Technology from Jubail Industrial College, where I completed my studies over three and a half years. With over six years of experience as a Chemical Laboratory Technician in Saudi Aramco, Exploration Core Laboratories Center, I have developed extensive skills in operating the ED-XRF machine for geological sample analysis, utilizing XRD techniques for mineralogical studies, and conducting palynological research. I was also responsible for processing rock samples, coordinating field operations, and documenting data using the Oracle database system. My experience has provided me with strong capabilities in data analysis, project management, and effective communication. I am confident that my background and skills can add significant value to your team, and I am eager to contribute to your company’s ambitious projects and goals.